Skip to main content
Journal cover image

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.

Publication ,  Journal Article
Faxon, DP; Eikelboom, JW; Berger, PB; Holmes, DR; Bhatt, DL; Moliterno, DJ; Becker, RC; Angiolillo, DJ
Published in: Thrombosis and haemostasis
October 2011

The optimal regimen of the anticoagulant and antiplatelet therapies in patients with atrial fibrillation who have had a coronary stent is unclear. It is well recognised that "triple therapy" with aspirin, clopidogrel, and warfarin is associated with an increased risk of bleeding. National guidelines have not made specific recommendations given the lack of adequate data. In choosing the best antithrombotic options for a patient, consideration needs to be given to the risks of stroke, stent thrombosis and major bleeding. This document describes these risks, provides specific recommendations concerning vascular access, stent choice, concomitant use of proton-pump inhibitors and the use and duration of triple therapy following stent placement based upon the risk assessment.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Thrombosis and haemostasis

DOI

EISSN

2567-689X

ISSN

0340-6245

Publication Date

October 2011

Volume

106

Issue

4

Start / End Page

572 / 584

Related Subject Headings

  • Warfarin
  • Thrombosis
  • Stents
  • Risk
  • Postoperative Complications
  • Platelet Aggregation Inhibitors
  • North America
  • Humans
  • Hemorrhage
  • Drug Therapy, Combination
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Faxon, D. P., Eikelboom, J. W., Berger, P. B., Holmes, D. R., Bhatt, D. L., Moliterno, D. J., … Angiolillo, D. J. (2011). Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thrombosis and Haemostasis, 106(4), 572–584. https://doi.org/10.1160/th11-04-0262
Faxon, David P., John W. Eikelboom, Peter B. Berger, David R. Holmes, Deepak L. Bhatt, David J. Moliterno, Richard C. Becker, and Dominick J. Angiolillo. “Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.Thrombosis and Haemostasis 106, no. 4 (October 2011): 572–84. https://doi.org/10.1160/th11-04-0262.
Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thrombosis and haemostasis. 2011 Oct;106(4):572–84.
Faxon, David P., et al. “Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.Thrombosis and Haemostasis, vol. 106, no. 4, Oct. 2011, pp. 572–84. Epmc, doi:10.1160/th11-04-0262.
Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thrombosis and haemostasis. 2011 Oct;106(4):572–584.
Journal cover image

Published In

Thrombosis and haemostasis

DOI

EISSN

2567-689X

ISSN

0340-6245

Publication Date

October 2011

Volume

106

Issue

4

Start / End Page

572 / 584

Related Subject Headings

  • Warfarin
  • Thrombosis
  • Stents
  • Risk
  • Postoperative Complications
  • Platelet Aggregation Inhibitors
  • North America
  • Humans
  • Hemorrhage
  • Drug Therapy, Combination